🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

393,17 USD

Máx. histórico

447,03

14 días

Split 2:1 del 22/11/1999

Caída desde máximo

-12,05%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-10,08%

Cierre anterior

437,23

Rango de hoy

391,17 – 410,03

Volumen hoy

6.589.429

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
24,44 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 3 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,53%
Fecha de pago Importe por participación
14/02/2019 1,4500 USD
15/11/2018 1,3200 USD
16/08/2018 1,3200 USD
16/05/2018 1,3200 USD
14/02/2018 1,3200 USD
16/11/2017 1,1500 USD
15/08/2017 1,1500 USD
15/05/2017 1,1500 USD
13/02/2017 1,1500 USD
14/11/2016 1,0000 USD
15/08/2016 1,0000 USD
13/05/2016 1,0000 USD
11/02/2016 1,0000 USD
12/11/2015 0,7900 USD
13/08/2015 0,7900 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/04/2006 70,00 70,52 69,10 69,61 -0,66% 2,03% 9.411.400
13/04/2006 69,85 70,21 69,56 70,07 +0,14% 0,93% 7.537.900
12/04/2006 70,03 70,99 69,53 69,97 -0,38% 2,08% 8.408.200
11/04/2006 70,94 71,05 69,48 70,24 -0,71% 2,21% 8.550.500
10/04/2006 71,35 71,53 70,34 70,74 -0,41% 1,67% 6.131.500
07/04/2006 72,28 72,49 70,61 71,03 -1,14% 2,60% 8.248.800
06/04/2006 72,56 73,12 71,41 71,85 -1,39% 2,36% 9.637.600
05/04/2006 72,10 73,07 71,90 72,86 +1,17% 1,62% 12.862.300
04/04/2006 71,93 72,28 71,61 72,02 +0,19% 0,93% 9.649.900
03/04/2006 73,46 73,50 71,68 71,88 -1,20% 2,48% 10.609.400
31/03/2006 72,89 73,35 72,66 72,75 +0,18% 0,95% 8.828.100
30/03/2006 72,15 73,32 72,12 72,62 +0,83% 1,66% 7.623.500
29/03/2006 72,63 73,15 71,81 72,02 -0,81% 1,84% 6.687.100
28/03/2006 73,42 73,82 72,25 72,61 -0,67% 2,14% 9.298.900
27/03/2006 72,75 73,36 72,26 73,10 -0,11% 1,51% 5.824.900
24/03/2006 72,57 73,57 72,45 73,18 +0,52% 1,54% 4.589.900
23/03/2006 72,20 72,88 71,80 72,80 +0,51% 1,50% 5.466.400
22/03/2006 71,75 72,74 71,35 72,43 +0,64% 1,94% 6.687.700
21/03/2006 71,97 73,09 71,55 71,97 -1,21% 2,14% 8.702.200
20/03/2006 73,36 73,45 72,37 72,85 -0,55% 1,47% 6.181.200
17/03/2006 73,66 73,84 72,52 73,25 -0,80% 1,79% 19.701.800
16/03/2006 74,53 74,71 73,65 73,84 -1,40% 1,42% 8.922.000
15/03/2006 75,05 75,48 74,38 74,89 -0,16% 1,47% 5.249.500
14/03/2006 73,47 75,06 73,31 75,01 +1,93% 2,38% 8.457.600
13/03/2006 73,75 73,94 73,29 73,59 +0,14% 0,88% 6.001.300
10/03/2006 73,29 73,80 72,82 73,49 -0,12% 1,34% 7.549.500
09/03/2006 74,23 74,45 73,58 73,58 -0,84% 1,17% 6.996.500
08/03/2006 73,39 74,69 73,27 74,20 +0,56% 1,93% 6.763.800
07/03/2006 73,65 74,25 73,31 73,79 +0,33% 1,28% 6.701.100
06/03/2006 75,40 75,50 73,50 73,55 -2,44% 2,65% 7.087.800